Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.700
-0.040 (-0.84%)
At close: Jul 31, 2026, 4:00 PM EDT
4.705
+0.005 (0.11%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $376.13 million as of July 31, 2026. Its market cap has increased by 19.76% in one year.
Market Cap
376.13M
Enterprise Value
120.76M
1-Year Change
19.76%
Ranking
Category
Stock Price
$4.70
ChartMarket Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $376.13M, a decrease of -80.59%. That is a compound annual growth rate of -24.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 376.13M | 34.85% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 401.45M |
| Sutro Biopharma | 400.51M |
| Larimar Therapeutics | 398.74M |
| Autolus Therapeutics | 396.55M |
| Editas Medicine | 395.93M |
| C4 Therapeutics | 384.77M |
| X4 Pharmaceuticals | 375.39M |
| Scribe Therapeutics | 367.48M |